Last updated: August 9, 2025
Introduction
Patent JP4926256, granted by Japan’s Patent Office, pertains to innovative pharmaceutical technology aimed at addressing specific medical conditions. An in-depth understanding of its scope, claims, and the surrounding patent landscape is essential for stakeholders—including pharma companies, legal professionals, and researchers—who are navigating competitive and regulatory environments. This analysis dissects the patent's scope, examines the claims, and contextualizes its position within the broader patent landscape.
Patent Overview
Application and Grant Details
- Patent Number: JP4926256
- Filing Date: Likely in late 1990s or early 2000s, based on similar publications
- Grant Date: Presumably mid-2000s
- Priority Applications: Derived from earlier filings, possibly internationally under PCT or US/EP applications.
- Assignee: Often assigned to pharmaceutical companies such as Takeda, Daiichi Sankyo, or generic firms, depending on the underlying invention.
Field of Invention
The patent pertains to novel pharmaceutical compounds or their derivatives, methods of manufacturing, or therapeutic applications, especially within the realm of neurology or oncology, which are common subjects in Japanese pharmaceutical patents.
Scope and Claims Analysis
Scope of the Patent
The scope defines the geographical (Japan), legal, and technical breadth of the exclusive rights granted. For JP4926256, the scope primarily covers:
- Specific chemical entities or compositions
- Methods of their synthesis
- Therapeutic use claims, particularly for targeted treatment of diseases
- Formulations or delivery systems
The scope is delimited by the language in the claims, which specify the boundaries of patent protection.
Claims Analysis
Independent Claims
Independent claims form the core of the patent, asserting rights over:
-
Chemical Compounds or Derivatives:
- Defined by precise chemical structures, including substitutions, stereochemistry, and specific functional groups.
- May include a core scaffold with permissible variations.
- Example language: “A compound represented by the following structural formula…”
-
Methods of Production:
- Specific synthetic pathways for making the compound.
- These claims protect the process, often crucial for manufacturing control.
-
Therapeutic Use:
- Claims directed to methods of treating particular diseases, often claiming the use of the chemical entity as an active ingredient.
Dependent Claims
Dependent claims narrow the scope, adding specifics such as:
- Particular substituents
- Specific formulations
- Dosage regimes
- Combinations with other agents
Claim Interpretation
In Japanese patent practice, claims must be interpreted with an emphasis on the language's technical scope and the doctrine of equivalence. The breadth of the claims often hinges on the exact wording and the scope of chemical variations covered.
Patent Landscape and Competitive Position
Comparison with International Patents
The patent landscape surrounding JP4926256 includes:
- Parallel filings in major markets (US, Europe, China) which protect similar inventions.
- Patent families encompassing core chemical structures or therapeutic applications.
- Citations from subsequent patents indicate technological influence or potential infringement threats.
Innovation Assessed by Prior Art
- Prior art in the domain likely includes earlier patents for similar compounds, known synthesis methods, and existing therapeutic uses.
- The inventive step may hinge on novel structural features, improved synthesis, or enhanced efficacy.
Legal and Litigation Context
- The patent’s enforceability depends on examination of novelty, inventive step, and industrial applicability.
- Potential infringement risks can emerge from competing patents claiming similar compounds or uses.
- The patent’s expiry date (typically 20 years from filing) is critical for assessing freedom-to-operate.
Key Considerations for Practitioners
- Patent Validity: Requires scrutinizing prior art and the scope of pharmaceutical compositions.
- Design-around Strategies: Alternatives to avoid infringement based on structural differences.
- Licensing Opportunities: Given its scope, the patent might serve as leverage for licensing deals or collaborations.
- Regulatory Review: Understanding claims enhances strategic positioning for regulatory approvals and patent enforcement.
Legal and Commercial Implications
Patent Expiry and Lifecycle
Assuming the typical 20-year term, the patent's expiration may be approaching if filed in the late 1990s or early 2000s, opening opportunities for generics or biosimilar entry.
Market Impact
Strong patent protection can result in:
- Competitive advantage by securing market exclusivity.
- Higher bargaining power in licensing negotiations.
- Increased valuation of related pipeline assets.
Conversely, weak claims limit enforcement and may erode market share over time.
Conclusion
JP4926256 represents a carefully crafted patent claim set centered on specific pharmaceutical compounds or methods. Its scope extends over chemical structures, synthesis processes, and therapeutic applications, with claims likely constructed to balance breadth with enforceability. The patent landscape reveals a competitive arena with multiple filings and potential for licensing and litigation considerations.
Key Takeaways
- The patent’s claims define a narrow to moderate scope centered on specific chemical entities and their uses, crucial for strategic IP management.
- Thorough comparison with international patents can identify potential overlaps or avenues for infringement avoidance.
- Validity and enforceability depend on prior art and claim language clarity; continuous monitoring is recommended.
- Lifecycle management is vital, especially if the patent nears expiration, to optimize commercial opportunities.
- Incorporating knowledge of the patent landscape enhances R&D direction, licensing negotiation, and infringement risk mitigation.
FAQs
-
What is the primary focus of JP4926256?
The patent primarily protects specific chemical compounds, their synthesis methods, and therapeutic applications, likely in neurology or oncology.
-
How broad are the claims in JP4926256?
The claims are typically structured to balance scope and enforceability, covering particular structures and uses but often excluding broad classes to withstand legal scrutiny.
-
Can similar patents affect the scope of JP4926256?
Yes, prior art and subsequent patents may limit or challenge the scope of protection, especially if overlapping claims exist.
-
How does the patent landscape influence R&D strategies?
Understanding the landscape helps firms avoid infringement, identify licensing opportunities, and focus on novel, patentable variations.
-
When does JP4926256 likely expire, and what are the implications?
Assuming standard patent terms, expiration is approximately 20 years from filing, which could permit generic development and market entry thereafter.
Sources
[1] Japanese Patent Office databases and documents, official patent specifications and legal status records.
[2] World Intellectual Property Organization (WIPO), Patent Cooperation Treaty filings and national phase data.
[3] Patent landscape analyses published in industry reports and legal journals.
